The nutraceutical industry has never had more innovative ingredients, yet many continue to face the same challenge: poor absorption. Without effective delivery, even the most promising active ingredient may fail to achieve its intended physiological effect. As brands seek to differentiate their products in an increasingly crowded marketplace, delivery systems are becoming a critical factor in determining product performance, consumer outcomes, and commercial success.
In this episode of Spotlight On, George Kokkinis, CEO & Founder of Pharmako Biotechnologies, examines the evolving role of advanced delivery systems in modern nutraceutical development and why pharmacokinetic testing is emerging as an essential tool for validating their effectiveness.
The discussion will explore how delivery technologies can influence the absorption, distribution and availability of poorly absorbed bioactives, helping formulators unlock the full potential of ingredients that might otherwise deliver limited benefits. George will discuss the science behind improving bioavailability, the challenges associated with measuring performance, and why pharmacokinetic data provides a more meaningful understanding of how a formulation behaves in the body.
Listeners will gain insight into the relationship between formulation design, delivery technology and measurable outcomes, as well as the importance of generating robust scientific evidence to support product claims. The conversation will also address the industry’s growing need to move beyond theoretical improvements and demonstrate real-world biological relevance through appropriate testing and substantiation.
